Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 8/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 8/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 8/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 8/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.32 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7102466 | 1.00 | CHRNB2 (0.35) | CHRNB2CHRNB4CHRNA3CHRNA4EGLN1 | |
| SCHEMBL7104089 | 0.90 | CHRNB2 (0.38) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL7099348 | 0.90 | CHRNB2 (0.38) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL7098866 | 0.88 | EGLN1 (0.35) | EGLN1HRH2HRH1HRH4HRH3 | |
| SCHEMBL7487049 | 0.88 | EGLN1 (0.35) | EGLN1HRH2HRH1HRH4HRH3 | |
| SCHEMBL7098852 | 0.87 | ALDH1A1 (0.39) | CHRNB2CHRNA4 | |
| SCHEMBL7098381 | 0.87 | ALDH1A1 (0.39) | CHRNB2CHRNA4 | |
| SCHEMBL7097540 | 0.86 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4EGLN1 | |
| SCHEMBL7104068 | 0.86 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4EGLN1 | |
| SCHEMBL7098888 | 0.86 | EGLN1 (0.33) | EGLN1HRH2HRH1HRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003500402-A | — | — | 2003-01-07 | — | — | JP | claimed |
| EP-1178982-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2002-02-13 | — | — | EP | claimed |
| WO-2000071534-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2000-11-30 | — | — | WO | claimed |
| EP-1178982-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000071534-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2000-11-30 | — | — | WO | disclosed |